Blackhawk Capital Partners »

Vertex Pharmaceuticals Incorporated shares owned by Blackhawk Capital Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Blackhawk Capital Partners from 13F filings

Historical chart of Blackhawk Capital Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Blackhawk Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Blackhawk Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $214k 547 391.64
2021-12-31 $208k 945 220.11
2021-06-30 $220k 1.0k 215.26
2018-06-30 $48k 295 162.71
2018-03-31 $48k 295 162.71
2017-12-31 $115k 770 149.35

More positions owned by Blackhawk Capital Partners

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Meta Platforms Cl A (META)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Harrow Health (HROW)
First Tr Exchange-traded Senior Ln Fd (FTSL)
First Tr Exchange-traded First Tr Ta Hiyl (HYLS)
Eli Lilly & Co. (LLY)
First Tr Exch Traded Fd Iii Managd Mun Etf (FMB)
Netflix (NFLX)

View all positions for Blackhawk Capital Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated